icrf 193 has been researched along with staurosporine in 1 studies
| Studies (icrf 193) | Trials (icrf 193) | Recent Studies (post-2010) (icrf 193) | Studies (staurosporine) | Trials (staurosporine) | Recent Studies (post-2010) (staurosporine) |
|---|---|---|---|---|---|
| 155 | 0 | 30 | 6,272 | 58 | 976 |
| Protein | Taxonomy | icrf 193 (IC50) | staurosporine (IC50) |
|---|---|---|---|
| Chain A, Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | 0.0003 | |
| Chain X, Tyrosine-protein kinase Lyn | Homo sapiens (human) | 0.0013 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kramer, R; Lassota, P; Singh, G | 1 |
1 other study(ies) available for icrf 193 and staurosporine
| Article | Year |
|---|---|
Mechanism of topoisomerase II inhibition by staurosporine and other protein kinase inhibitors.
Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Animals; Cinnamates; Crithidia fasciculata; Diketopiperazines; DNA; Enzyme Inhibitors; Etoposide; Indoles; Maleimides; Piperazines; Protein Kinase Inhibitors; Staurosporine; Topoisomerase II Inhibitors | 1996 |